ALC
Alcon Inc
NYSE · Health Care
$78.83
+0.46 (+0.59%)
Income Statement
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Revenue | 7.75B | 7.30B | 7.81B | 7.70B | 7.03B |
| Net Income | 795.63M | 674.71M | 1.31B | 1.24B | 1.01B |
| EPS | — | — | — | — | — |
| Profit Margin | 10.3% | 9.8% | 16.8% | 16.1% | 14.4% |
| Rev Growth | +6.1% | +6.1% | +10.9% | -7.0% | +7.9% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Total Debt | 2.95B | 2.95B | 2.62B | 2.74B | 2.61B |
| Total Equity | 12.38B | 12.38B | 24.05B | 21.87B | 25.67B |
| D/E Ratio | 0.24 | 0.24 | 0.11 | 0.13 | 0.10 |
Cash Flow
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| EBITDA | 1.47B | 1.31B | 2.13B | 1.98B | 1.80B |
| Free Cash Flow | — | — | 1.04B | 976.52M | 785.68M |